Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
skip to main content
research-article

Formalizing MedDRA to support semantic reasoning on adverse drug reaction terms

Published: 01 June 2014 Publication History

Abstract

Graphical abstractDisplay Omitted MedDRA's current format limits accurate and consistent term selection for coding.OntoADR, a formalized ("ontologized") version of MedDRA can improve MedDRA coding and support signal detection.OntoADR is an OWL representation of MedDRA using SNOMED-CT formal definitions.Formalizing MedDRA enables terminological reasoning on terms semantics.The process of formalization of MedDRA can be semi-automated. Although MedDRA has obvious advantages over previous terminologies for coding adverse drug reactions and discovering potential signals using data mining techniques, its terminological organization constrains users to search terms according to predefined categories. Adding formal definitions to MedDRA would allow retrieval of terms according to a case definition that may correspond to novel categories that are not currently available in the terminology. To achieve semantic reasoning with MedDRA, we have associated formal definitions to MedDRA terms in an OWL file named OntoADR that is the result of our first step for providing an "ontologized" version of MedDRA. MedDRA five-levels original hierarchy was converted into a subsumption tree and formal definitions of MedDRA terms were designed using several methods: mappings to SNOMED-CT, semi-automatic definition algorithms or a fully manual way. This article presents the main steps of OntoADR conception process, its structure and content, and discusses problems and limits raised by this attempt to "ontologize" MedDRA.

References

[1]
ICH guideline E2B (R2), Electronic transmission of individual case safety reports - Message specification (ICH ICSR DTD Version 2.1), Final Version 2.3, Document Revision February 1, 2001.
[2]
MedDRA MSSO website. <http://www.meddramsso.com/>.
[3]
E.G. Brown, Methods and pitfalls in searching drug safety databases utilising the medical dictionary for regulatory activities (MedDRA), Drug Saf, 26 (2003) 145-158.
[4]
E.G. Brown, Using MedDRA, Drug saf, 27 (2004) 591-602.
[5]
MedDRA Data Retrieval and Presentation: Points to Consider. ICH-Endorsed Guide for MedDRA Users on Data Output. Release 3.2, based on MedDRA Version 14.1. 1 October 2011.
[6]
P. Mozzicato, Standardised MedDRA queries: their role in signal detection, Drug Saf, 30 (2007) 617-619.
[7]
C. Bousquet, G. Lagier, A. Lillo-Le Louët, C. Le Beller, A. Venot, M.C. Jaulent, Appraisal of the MedDRA conceptual structure for describing and grouping adverse drug reactions, Drug Saf, 28 (2005) 19-34.
[8]
G. Merrill, The MedDRA paradox, AMIA Annu Symp Proc, 6 (2008) 470-474.
[9]
S.A. Goldman, Adverse event reporting and standardized medical terminologies: strengths and limitations, Drug Inf J, 36 (2002) 439-444.
[10]
R.L. Richesson, K.W. Fung, J.P. Krischer, Heterogeneous but "standard" coding systems for adverse events: issues in achieving interoperability between apples and oranges, Contemp Clin Trials, 29 (2008) 635.
[11]
P.M. Nadkarni, J.A. Darer, Determining correspondences between highfrequency MedDRA concepts and SNOMED: a case study, BMC Med Inform Decis Mak, 10 (2010) 66.
[12]
A. Rossi Mori, F. Consorti, E. Galeazzi, Standards to support development of terminological systems for healthcare telematics, Methods Inform Med, 37 (1998) 551-563.
[13]
MedDRA Introductory Guide Version 14.0. MSSO-DI-6003-14.0.0. March 2011.
[14]
MedDRA Term Selection: Points to Consider. ICH-Endorsed Guide for MedDRA Users. Release 4.5, based on MedDRA Version 16.0. 1 April 2013.
[15]
C. Tonéatti, Y. Saïdi, V. Meiffrédy, P. Tangre, M. Harel, V. Eliette, Experience using MedDRA for global events coding in HIV clinical trials, Contemp Clin Trials, 27 (2006) 13-22.
[16]
L. Tremmel, L. Scarpone, Using MedDRA for adverse events in cancer trials: experience, caveats, and advice, Drug Inf J, 35 (2001) 845-852.
[17]
J.B. Schroll, E. Maund, P.C. Gøtzsche, Challenges in coding adverse events in clinical trials: a systematic review, PLoS ONE, 7 (2012) e41174.
[18]
S. Borgo, P. Leitao, The role of foundational ontologies in manufacturing domains, Lecture Notes Comput Sci, 3290 (2004) 670-688.
[19]
I.F. Cruz, X. Huiyong, The role of ontologies in data integration, Eng Intell Syst Elect, 13 (2005) 245-252.
[20]
Masolo C, Borgo S, Gangemi A, Guarino N, Oltramaria A. WonderWeb Deliverable D18 Ontology Library (final). Internal report, IST Project 2001-33052 WonderWeb: Ontology Infrastructure for the, Semantic Web; 2003.
[21]
M. Musen, V. Maojo, J. Crespo, M. García-Remesal, D. de la Iglesia, D. Perez-Rey, Discussion of biomedical ontologies: toward scientific debate, Methods Inform Med, 50 (2011) 226-227.
[22]
Wache H, Vögele T, Visser U, Stuckenschmidt H, Schuster G, Neumann H, Hübner S. Ontology-based integration of information. A survey of existing approaches. In: Stuckenschmidt H, editor. IJCAI-01 Workshop: Ontologies and Information Sharing 2001:108-117.
[23]
C. Bousquet, C. Henegar, A. Lillo-Le Louet, P. Degoulet, MC. Jaulent, Implementation of automated signal generation in pharmacovigilance using a knowledge-based approach, Int J Med Inform, 74 (2005) 563-571.
[24]
E.G. Brown, Effects of coding dictionary on signal generation: a consideration of use of MedDRA compared with WHO-ART, Drug Saf, 25 (2002) 445-452.
[25]
M. Yokotsuka, M. Aoyama, K. Kubota, The use of a medical dictionary for regulatory activities terminology (MedDRA) in prescription-event monitoring in Japan (J-PEM), Int J Med Inform, 57 (2000) 139-153.
[26]
C. Henegar, C. Bousquet, A. Lillo-Le Louët, P. Degoulet, MC. Jaulent, Building an ontology of adverse drug reactions for automated signal generation in pharmacovigilance, Comput Biol Med, 36 (2006) 748-767.
[27]
C. Henegar, C. Bousquet, A. Lillo-Le Louët, P. Degoulet, M.C. Jaulent, A knowledge-based approach for automated signal generation, Proc Medinfo (2004) 626-630.
[28]
SNOMED-CT Website. <http://www.ihtsdo.org/SNOMED-CT/>.
[29]
D.A.B. Lindberg, B.L. Humphreys, A.T. McCray, The unified medical language system, Methods Inform Med, 32 (1993) 281-291.
[30]
UMLS Website. <http://www.nlm.nih.gov/research/umls/>.
[31]
Bioportal Website. <http://bioportal.bioontology.org/>.
[32]
O. Bodenreider, Using SNOMED-CT in combination with MedDRA for reporting signal detection and adverse drug reactions reporting, AMIA Annu Symp Proc, 14 (2009) 45-49.
[33]
I. Alecu, C. Bousquet, F. Mougin, M.C. Jaulent, Mapping of the WHO-ART terminology on SNOMED-CT to improve grouping of related adverse drug reactions, Stud Health Technol Inform, 124 (2006) 833-838.
[34]
S. Schulz, S. Schober, I. Tudose, H. Stenzhorn, The pitfalls of thesaurus ontologization. The case of the NCI thesaurus, AMIA Annu Symp Proc (2010) 727-731.
[35]
J. Ingenerf, R. Linder, Assessing applicability of ontological principles to different types of biomedical vocabularies, Methods Inform Med, 48 (2009) 459.
[36]
J.J. Cimino, Desiderata for controlled medical vocabularies in the twenty-first century, Methods Inform Med, 37 (1998) 394-403.
[37]
A. Rector, S. Brandt, Why do it the hard way? The case for an expressive description logic for SNOMED, J Am Med Inform Assoc, 15 (2008) 744-751.
[38]
S. Schulz, R. Cornet, K. Spackman, Consolidating SNOMED CT's ontological commitment, Appl Ontol, 6 (2011) 1-11.
[39]
G. Héja, G. Surján, P. Varga, Ontological analysis of SNOMED-CT, BMC Med Inform Decis Mak, 8 (2008) S8.
[40]
SNOMED Clinical Terms¿ User Guide, 2010 July International Release.
[41]
EL description, W3C OWL working group. <http://www.w3.org/2007/OWL/wiki/EL>.
[42]
OWL 2 Web Ontology Language Profiles (Second Edition), W3C Recommendation 11 December 2012. <http://www.w3.org/TR/owl2-profiles/>.
[43]
G. Trifirò, A. Pariente, P.M. Coloma, J.A. Kors, G. Polimeni, G. Miremont-Salamé, EU-ADR group. Data mining on electronic health record databases for signal detection in pharmacovigilance. which events to monitor?, Pharmacoepidemiol Drug Saf, 18 (2009) 1176-1184.
[44]
G. Declerck, C. Bousquet, M.C. Jaulent, Automatic generation of MedDRA terms groupings using an ontology, Stud Health Technol Inform, 180 (2012) 73-77.
[45]
C. Golbreich, S. Zhang, O. Bodenreider, The foundational model of anatomy in OWL: experience and perspectives, Web Semantics: Science, Services and Agents on the World Wide Web, 4 (2006) 181-195.
[46]
M.E. Aranguren, S. Bechhofer, P. Lord, U. Sattler, R. Stevens, Understanding and using the meaning of statements in a bio-ontology: recasting the Gene Ontology in OWL, BMC Bioinform, 8 (2007) 57.
[47]
N.F. Noy, S. de Coronado, H. Solbrig, G. Fragoso, F.W. Hartel, M.A. Musen, Representing the NCI Thesaurus in OWL DL: modeling tools help modeling languages, Appl Ontol, 3 (2008) 173-190.
[48]
Möller M, Sintek M, Biedert R, Ernst P, Dengel A, Sonntag D. Representing the International Classification of Diseases Version 10 in OWL. Proc KEOD 2010, 50-59.
[49]
Chute C, í'stün B, Spackman K. Ontology-based convergence of medical terminologies: SNOMED CT and ICD-11. In: Proceedings of the eHealth2012. 2012 May 10-11; Vienna, Austria. OCG; 2012.
[50]
R.K. Pearson, M. Hauben, D.I. Goldsmith, A.L. Gould, D. Madigan, D.J. O'Hara, Influence of the MedDRA hierarchy on pharmacovigilance data mining results, Int J Med Inform, 78 (2009) 97-103.
[51]
Hill R, Hopstadius J, Lerch M, Noren N. An attempt to expedite signal detection by grouping related adverse reaction terms, Worshop "Computational methods in pharmacovigilance", In: 24th European Medical Informatics Conference (MIE 2012), 26-29 August 2012, Pisa (Italy). Drug Saf 2012; 35 (12): 1194-5.
[52]
J. Souvignet, G. Declerck, B. Trombert, J.M. Rodrigues, M.C. Jaulent, C. Bousquet, Evaluation of automated term groupings for detecting anaphylactic shock signals with drugs, AMIA Annu Symp Proc, 2012 (2012) 882-890.
[53]
J. Souvignet, G. Declerck, M.-C. Jaulent, C. Bousquet, Evaluation of automated term groupings for detecting upper gastrointestinal bleeding signals for drugs, Drug Saf, 35 (2012) 1195-1196.

Cited By

View all
  • (2016)OntoADR a semantic resource describing adverse drug reactions to support searching, coding, and information retrievalJournal of Biomedical Informatics10.1016/j.jbi.2016.06.01063:C(100-107)Online publication date: 1-Oct-2016

Index Terms

  1. Formalizing MedDRA to support semantic reasoning on adverse drug reaction terms
      Index terms have been assigned to the content through auto-classification.

      Recommendations

      Comments

      Information & Contributors

      Information

      Published In

      cover image Journal of Biomedical Informatics
      Journal of Biomedical Informatics  Volume 49, Issue C
      June 2014
      297 pages

      Publisher

      Elsevier Science

      San Diego, CA, United States

      Publication History

      Published: 01 June 2014

      Author Tags

      1. Adverse drug reaction
      2. MedDRA
      3. Ontology
      4. SNOMED-CT
      5. Semantic reasoning
      6. Terminology

      Qualifiers

      • Research-article

      Contributors

      Other Metrics

      Bibliometrics & Citations

      Bibliometrics

      Article Metrics

      • Downloads (Last 12 months)0
      • Downloads (Last 6 weeks)0
      Reflects downloads up to 03 Sep 2024

      Other Metrics

      Citations

      Cited By

      View all
      • (2016)OntoADR a semantic resource describing adverse drug reactions to support searching, coding, and information retrievalJournal of Biomedical Informatics10.1016/j.jbi.2016.06.01063:C(100-107)Online publication date: 1-Oct-2016

      View Options

      View options

      Get Access

      Login options

      Media

      Figures

      Other

      Tables

      Share

      Share

      Share this Publication link

      Share on social media